Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy
Open Access
- 21 July 1997
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 186 (2), 229-238
- https://doi.org/10.1084/jem.186.2.229
Abstract
One enigma in tumor immunology is why animals bearing malignant grafts can reject normal grafts that express the same nonself-antigen. An explanation for this phenomenon could be that different T cell clones react to the normal graft and the malignant cells, respectively, and only the tumor-reactive clonotypes may be affected by the growing tumor. To test this hypothesis, we used a T cell receptor transgenic mouse in which essentially all CD8+ T cells are specific for a closely related set of self-peptides presented on the MHC class I molecule Ld. We find that the tumor expressed Ld in the T cell receptor transgenic mice but grew, while the Ld-positive skin was rejected. Thus, despite an abundance of antigen-specific T cells, the malignant tissue grew while normal tissue expressing the same epitopes was rejected. Therefore, systemic T cell exhaustion or anergy was not responsible for the growth of the antigenic cancer cells. Expression of costimulatory molecules on the tumor cells after transfection and preimmunization by full-thickness skin grafts was required for rejection of a subsequent tumor challenge, but there was no detectable effect of active immunization once the tumor was established. Thus, the failure of established tumors to attract and activate tumor-specific T cells at the tumor site may be a major obstacle for preventive or therapeutic vaccination against antigenic cancer.Keywords
This publication has 37 references indexed in Scilit:
- Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.The Journal of Experimental Medicine, 1996
- Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the diseaseInternational Journal of Cancer, 1995
- Peripheral clonal deletion of antiviral memory CD8+ T cellsEuropean Journal of Immunology, 1993
- Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.The Journal of Experimental Medicine, 1990
- Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic miceNature, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984